Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revised GMP reg's effective date to be delayed until mid-1998 to conform to EU deadline.

This article was originally published in The Gray Sheet

Executive Summary

REVISED GMP RULE EFFECTIVE DATE OF MID-1998 will be included in the final rule modifying FDA's device good manufacturing practices requirements. The design control provisions of the upcoming reg harmonize device GMPs with European quality systems requirements, and FDA wants to align the effective date of its rule with the June 1998 date at which QS requirements take effect for most products through the medical devices directive.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel